Skip to content

Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants

Effects of Automated Adjustment of Inspired Oxygen on Fluctuations of Regional Cerebral and Arterial Oxygenation in Preterm Infants With Frequent Desaturations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01942473
Acronym
FiO2-Contr
Enrollment
17
Registered
2013-09-16
Start date
2012-08-31
Completion date
2014-04-30
Last updated
2014-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Infant, RDS

Brief summary

In this study the investigators test the hypothesis that automated FiO2 adjustment increases the time of brain tissue oxygenation within the intended reference range. Furthermore, the investigators studied the change in workload during automated FiO2 adjustment as compared to manual adjustment by the nursing staff.

Detailed description

Recorded data on brain tissue oxygenation will be compared with reference data obtained from other studies. Data from experimental mode (automated FiO2 control will be compared with manual FiO2 control).

Interventions

DEVICEAutomated FiO2 Control

Infants will be ventilated with or without automated FiO2-Control in a randomized sequence.

Sponsors

University of Ulm
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
96 Hours to 30 Weeks
Healthy volunteers
No

Inclusion criteria

* postmenstrual age \<30 wks GA at study time * on nasal/nasopharyngeal CPAP or mechanical ventilation (including nasopharyngeal IMV) * at least 4 desaturations (SpO2 \<80%) during an 8 hour period within the 24h before the study using a standard pulse oximeter incorporated in the NICU (Dash 3000, General Electric, Freiburg; 10s averaging time, delay 10s)

Exclusion criteria

* postnatal age \<96h (to exclude rapidly changing conditions during the early phase of RDS and to avoid handling of the infant during the critical period for IVH) * congenital cyanotic heart disease * no decision for full treatment support * Average FiO2 during the last 24h bevor the active study phase \>0.60 * Congenital malformations of the lung or the diaphragm (i.e. diaphragmatic hernia, congentital cystic lung diseases...) * Clinically clear evidence for seizures * Ongoing Sepsis (CRP \> 10mg/l, or positive blood culture, requirement of catecholamines) * Need of blood-transfusion during study

Design outcomes

Primary

MeasureTime frameDescription
Cerebral tissue oxygen saturation48 hoursmean cerebral tissue oxygen saturation as well als distribution of cerebral tissue oxygen saturation over time will be assessed

Secondary

MeasureTime frameDescription
number and mean duration of episodes with an SpO2 <80%, <75%, <70% and with hyperoxemia (SpO2 >96%)48 hoursThe number and mean duration of expisodes of desaturation and with hyperoxemia will be assessed
time within a defined target range of cerebral oxygen saturation (59% - 81%)48 hourstime (as measured as the percentage of the total recording time) within a defined target range of cerebral oxygen saturation (59% - 81%) which corresponds to the 10th and 90th percentile obtained from a pilot study in 16 preterm infants with desaturations during the time when their SpO2 was aimed within the target range of a SpO2 of (88-96%).
workload for the medical staff related to number of adjustments of FiO248 hours

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026